Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://mvnrepository.com
Are you over 18 and want to see adult content?
A complete backup of https://caracasarepabar.com
Are you over 18 and want to see adult content?
A complete backup of https://homejoyservice.com
Are you over 18 and want to see adult content?
A complete backup of https://sims-mod.ru
Are you over 18 and want to see adult content?
A complete backup of https://terrymcdonagh.com
Are you over 18 and want to see adult content?
A complete backup of https://seooneclick.com
Are you over 18 and want to see adult content?
A complete backup of https://marcellusdrilling.com
Are you over 18 and want to see adult content?
A complete backup of https://nuuvem.com.br
Are you over 18 and want to see adult content?
A complete backup of https://curiouscatblog.net
Are you over 18 and want to see adult content?
A complete backup of https://theburn.com
Are you over 18 and want to see adult content?
A complete backup of https://recette-americaine.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://brentwoodtn.gov
Are you over 18 and want to see adult content?
A complete backup of https://remaimodern.org
Are you over 18 and want to see adult content?
A complete backup of https://hoop-ball.com
Are you over 18 and want to see adult content?
A complete backup of https://topcasinoexpert.com
Are you over 18 and want to see adult content?
A complete backup of https://infoseemedia.com
Are you over 18 and want to see adult content?
A complete backup of https://scaramangashop.co.uk
Are you over 18 and want to see adult content?
A complete backup of https://smartvirtualphonenumber.com
Are you over 18 and want to see adult content?
A complete backup of https://beeline.kg
Are you over 18 and want to see adult content?
A complete backup of https://pearsoncanada.ca
Are you over 18 and want to see adult content?
A complete backup of https://triplepro.nl
Are you over 18 and want to see adult content?
A complete backup of https://about-autos.com
Are you over 18 and want to see adult content?
A complete backup of https://sheppyscider.com
Are you over 18 and want to see adult content?
Text
MENOPAUSE@MEANWOOD
The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT.MIGRAINE AND HRT
Introduction Fluctuating estrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective management of vasomotor symptoms can also result in improvement in migraine. What are the key points about managing perimenopausal women with migraine? Perimenopausal women with no history of migraine aura may DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. USE OF HORMONE THERAPY IN BRCA GENE CARRIERS A useful article published in “Menopause” has reviewed current information on the effect on breast cancer risk with the use of HRT after removal of ovaries for risk reducing surgery in women who carrythe BRCA gene.
BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRT BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT,MENOPAUSE@MEANWOOD
The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT.MIGRAINE AND HRT
Introduction Fluctuating estrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective management of vasomotor symptoms can also result in improvement in migraine. What are the key points about managing perimenopausal women with migraine? Perimenopausal women with no history of migraine aura may DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. USE OF HORMONE THERAPY IN BRCA GENE CARRIERS A useful article published in “Menopause” has reviewed current information on the effect on breast cancer risk with the use of HRT after removal of ovaries for risk reducing surgery in women who carrythe BRCA gene.
BMS 31ST ANNUAL SCIENTIFIC CONFERENCE Overview: We are hoping to offer our 31st BMS annual scientific conference as a two-day face to face meeting in 2022. We will continue to monitor government guidance in the coming months and final plans will be made accordingly.BIOIDENTICAL HRT
Introduction The aims of this paper are to clarify the: differences between custom ‘compounded’ bioidentical hormone replacement therapy (cBHRT) and conventionally prescribed ‘regulated’ bioidentical hormone replacement therapy (rBHRT) issues which have caused confusion regarding the regulation and prescribing of these hormones scientific rationale for the potential BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in HRT PREPARATIONS AND EQUIVALENT ALTERNATIVES The BMS has produced a document in response to the ongoing HRT shortages and to provide guidance to BMS members and clinical practitioners who may be THE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. CONFUSION OVER VAGINAL ESTROGEN Several types of vaginal estrogen are now available and can be extremely helpful for treatment of the effects of menopausal estrogen deficiency on the vagina and bladder. MENOPAUSE CLINIC, SOLENT SEXUAL HEALTH SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. EFFECT OF HRT ON SLEEP QUALITY Many women experience disturbed sleep as a menopausal symptom which can have a significant effect on mood and energy levels and causedistress.
RISK OF RECURRENT THROMBOSIS AFFECTED BY TYPE OF HRT It has been known for some time that oral (tablet) form of HRT is associated with a small increased risk of deep vein thrombosis and pulmonary embolus (venous thromboembolism, VTE), while transdermal HRT (patch or gel) is not thought to be associated. NUFFIELD HEALTH LEEDS The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRTMIGRAINE AND HRT
Migraine aura does not contraindicate HRT. Use non-oral bio-identical estrogen (patch or gel) Use the lowest estrogen dose that effectively controls vasomotor symptoms. Where progestogen is required continuous delivery is recommended, with preparations such as: levonorgestrel intrauterine system. transdermal norethisterone (as in combinedpatches)
BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT, POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT.MENOPAUSE@MEANWOOD
The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRTMIGRAINE AND HRT
Migraine aura does not contraindicate HRT. Use non-oral bio-identical estrogen (patch or gel) Use the lowest estrogen dose that effectively controls vasomotor symptoms. Where progestogen is required continuous delivery is recommended, with preparations such as: levonorgestrel intrauterine system. transdermal norethisterone (as in combinedpatches)
BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT, POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT.MENOPAUSE@MEANWOOD
The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. BMS 31ST ANNUAL SCIENTIFIC CONFERENCE Overview: We are hoping to offer our 31st BMS annual scientific conference as a two-day face to face meeting in 2022. We will continue to monitor government guidance in the coming months and final plans will be made accordingly. BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners inBIOIDENTICAL HRT
The 2015 NICE NG23 menopause diagnosis and management guideline 1.4.15 stated ‘Explain to women that the efficacy and safety of unregulated compounded bioidentical hormones are unknown.’. The 2016 Revised Global Consensus Statement of the key stakeholder societies1 (see below), initiated by the International Menopause Society, advised that THE MENOPAUSE CLINIC BMS specialist(s) working at this clinic: Mr Gerald Hackett, Consultant Gynaecologist. Further information: Clinic appointments available through GP referral to The Menopause Clinic (1st, 3rd and 5th Fridays of the month) HRT PREPARATIONS AND EQUIVALENT ALTERNATIVES HRT preparations and equivalent alternatives. Mariette-JB 2019-11-04T12:10:52+00:00. 4 November 2019. |. The BMS has produced this document in response to the ongoing HRT shortages and to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies. The objective of this isto provide
CONFUSION OVER VAGINAL ESTROGEN Confusion over vaginal estrogen. Several types of vaginal estrogen are now available and can be extremely helpful for treatment of the effects of menopausal estrogen deficiency on the vagina and bladder. Concern about risks of treatment for one preparation, high strength vaginal estradiol cream, (Linoladiol, Linoladiol N, LinoladiolEstradiol
EFFECT OF HRT ON SLEEP QUALITY Effect of HRT on sleep quality. Many women experience disturbed sleep as a menopausal symptom which can have a significant effect on mood and energy levels and cause distress. In addition poor sleep can lead to increased risk of cardiovascular disease, diabetes and obesity. The role of HRT in improving sleep quality is unclear but a recently HRT – PRACTICAL PRESCRIBING HRT – Practical prescribing Estradiol Estriol Conjugated estrogens > 0.5mg (combined only)/ 1mg / 2mg oral > 25mcg / 37.5mcg / 40mcg / 50mcg / 75mcg / 80mcg/ 100 mcg patches NUFFIELD HEALTH LEEDS The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. HRT USE AFTER HEART ATTACK The use of HRT in women who have had a heart attack (Myocardial Infarction, MI), continues to be controversial. While increasing evidence is emerging to suggest that the use of HRT in the early menopausal years may well be beneficial in preventing heart disease, it is generally advised that HRT should be stopped if a woman suffers from a heart attack. BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRT BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners inBIOIDENTICAL HRT
Introduction The aims of this paper are to clarify the: differences between custom ‘compounded’ bioidentical hormone replacement therapy (cBHRT) and conventionally prescribed ‘regulated’ bioidentical hormone replacement therapy (rBHRT) issues which have caused confusion regarding the regulation and prescribing of these hormones scientific rationale for the potential BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT,MIGRAINE AND HRT
Introduction Fluctuating estrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective management of vasomotor symptoms can also result in improvement in migraine. What are the key points about managing perimenopausal women with migraine? Perimenopausal women with no history of migraine aura may POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. TESTOSTERONE REPLACEMENT IN MENOPAUSE 1 How much and where does it come from?Testosterone is an important female hormone. Healthy young women produce approximately 100 – 400 mcg per day. This represents three to four times the amount of estrogen produced by the ovaries. Approximately half of endogenous testosterone and precursors are derived from the ovaries e.g.androstenedione and
UNDERSTANDING THE RISKS OF BREAST CANCER March 2017 23 cases of breast cancer diagnosed in the UK general population An additional four cases in women on combined hormone replacement therapy (HRT) BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRT BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners inBIOIDENTICAL HRT
Introduction The aims of this paper are to clarify the: differences between custom ‘compounded’ bioidentical hormone replacement therapy (cBHRT) and conventionally prescribed ‘regulated’ bioidentical hormone replacement therapy (rBHRT) issues which have caused confusion regarding the regulation and prescribing of these hormones scientific rationale for the potential BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT,MIGRAINE AND HRT
Introduction Fluctuating estrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective management of vasomotor symptoms can also result in improvement in migraine. What are the key points about managing perimenopausal women with migraine? Perimenopausal women with no history of migraine aura may POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. TESTOSTERONE REPLACEMENT IN MENOPAUSE 1 How much and where does it come from?Testosterone is an important female hormone. Healthy young women produce approximately 100 – 400 mcg per day. This represents three to four times the amount of estrogen produced by the ovaries. Approximately half of endogenous testosterone and precursors are derived from the ovaries e.g.androstenedione and
UNDERSTANDING THE RISKS OF BREAST CANCER March 2017 23 cases of breast cancer diagnosed in the UK general population An additional four cases in women on combined hormone replacement therapy (HRT) BMS 31ST ANNUAL SCIENTIFIC CONFERENCE Overview: We are hoping to offer our 31st BMS annual scientific conference as a two-day face to face meeting in 2022. We will continue to monitor government guidance in the coming months and final plans will be made accordingly.CARRIG CLINIC
The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. MENOPAUSE AND THE WORKPLACE In 2019, there are over 4.3 million employed women in the UK aged 45-60, and a significant number of these women will be working through their menopausal transition. Employers are being encouraged to offer awareness and support to this population of employees. You will find further information, sources of help and advice, and additional BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in STOCKPORT COMMUNITY GYNAECOLOGY SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. FIND A BMS-RECOGNISED MENOPAUSE SPECIALIST Find your nearest BMS-recognised menopause specialist. To find your nearest BMS-recognised menopause specialist, simply enter your postcode below (if this hasn’t been located automatically), select your chosen filters and click ‘search’. DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT.UROGENITAL ATROPHY
Summary Urogenital atrophy is more common than it would first appear and women do not always seek advice and guidance. Confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations but new treatment modalities have emerged that extend the range of options beyond lubricants, moisturisers and vaginal estrogen preparations. Practice points Urogenital MENOPAUSE CLINIC, ROYAL HALLAMSHIRE HOSPITAL BMS specialist(s) working at this clinic: Dr Sue Stillwell. Further information: This hospital based clinic accepts referrals from GP's, health care professionals and clinicians from Sheffield and thesurrounding area.
CARDIFF & SOUTH WALES WELL WOMAN AND MENOPAUSE CLINIC BMS specialist(s) working at this clinic: Mr David Griffiths, Consultant Gynaecologist. Further information: We provide a holistic approach to your care and offer a full range of gynaecological services and treatments. BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRT BMS 30TH ANNUAL SCIENTIFIC CONFERENCE Overview: We are delighted to offer our 30th BMS annual scientific conference as a virtual meeting this year. The virtual format offers you all the benefits of high-quality BMS education whilst recognising the current challenges we are all facing. FIND A BMS-RECOGNISED MENOPAUSE SPECIALIST Find your nearest BMS-recognised menopause specialist. To find your nearest BMS-recognised menopause specialist, simply enter your postcode below (if this hasn’t been located automatically), select your chosen filters and click ‘search’.BIOIDENTICAL HRT
Introduction The aims of this paper are to clarify the: differences between custom ‘compounded’ bioidentical hormone replacement therapy (cBHRT) and conventionally prescribed ‘regulated’ bioidentical hormone replacement therapy (rBHRT) issues which have caused confusion regarding the regulation and prescribing of these hormones scientific rationale for the potential BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT,MIGRAINE AND HRT
Introduction Fluctuating estrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective management of vasomotor symptoms can also result in improvement in migraine. What are the key points about managing perimenopausal women with migraine? Perimenopausal women with no history of migraine aura may DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. BRITISH MENOPAUSE SOCIETY The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health.This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRT BMS 30TH ANNUAL SCIENTIFIC CONFERENCE Overview: We are delighted to offer our 30th BMS annual scientific conference as a virtual meeting this year. The virtual format offers you all the benefits of high-quality BMS education whilst recognising the current challenges we are all facing. FIND A BMS-RECOGNISED MENOPAUSE SPECIALIST Find your nearest BMS-recognised menopause specialist. To find your nearest BMS-recognised menopause specialist, simply enter your postcode below (if this hasn’t been located automatically), select your chosen filters and click ‘search’.BIOIDENTICAL HRT
Introduction The aims of this paper are to clarify the: differences between custom ‘compounded’ bioidentical hormone replacement therapy (cBHRT) and conventionally prescribed ‘regulated’ bioidentical hormone replacement therapy (rBHRT) issues which have caused confusion regarding the regulation and prescribing of these hormones scientific rationale for the potential BMS & WHC’S 2020 RECOMMENDATIONS ON HORMONE REPLACEMENT Key points All women should be able to access advice on how they can optimise their menopause transition and the years beyond. There should be a holistic and individualised approach in assessing menopausal women, with particular reference to lifestyle advice, diet modification as well as discussion of the role of HRT. The decision whether to take HRT,MIGRAINE AND HRT
Introduction Fluctuating estrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective management of vasomotor symptoms can also result in improvement in migraine. What are the key points about managing perimenopausal women with migraine? Perimenopausal women with no history of migraine aura may DUMFRIES MENOPAUSE SERVICE The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. POOLE MENOPAUSE CLINIC The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. BRITISH MENOPAUSE SOCIETY FURTHER UPDATE ON HRT SUPPLY The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners on HRT product availability. The ongoing challenges brought on by the COVID-19 pandemic have resulted in many women experiencing difficulties in obtaining their HRT supplies. We appreciate that continuing HRT EDUCATION | BRITISH MENOPAUSE SOCIETY The BMS has developed a range of training programmes for healthcare professionals. We continue to emphasise the importance of education and good information but have also developed practical training to equip clinicians to respond to the needs of their patients. Working with a mentor or trainer to meet defined competency standards yourpractice can be
BIOIDENTICAL HRT
Introduction The aims of this paper are to clarify the: differences between custom ‘compounded’ bioidentical hormone replacement therapy (cBHRT) and conventionally prescribed ‘regulated’ bioidentical hormone replacement therapy (rBHRT) issues which have caused confusion regarding the regulation and prescribing of these hormones scientific rationale for the potential TOOLS FOR CLINICIANS To support women’s understanding of the menopause, the BMS has launched a number of materials for both women and healthcare professionals clarifying some of the most common myths and misconceptions of menopause, summarising the NICE guideline, and providing guidance on HRT. Information for women is available on the THE MENOPAUSE CLINIC BMS specialist(s) working at this clinic: Mr Gerald Hackett, Consultant Gynaecologist. Further information: Clinic appointments available through GP referral to The Menopause Clinic (1st, 3rd and 5th Fridays of the month)NICE GUIDELINE
The NICE Guideline: Diagnosis and Management of the Menopause on the diagnosis and management of the menopause was published on 12th November 2015 and will play an important role in raising awareness of all menopausal symptoms and in encouraging women to consider lifestyle changes to improve later health. The Guideline should also clarifyuncertainty -
HRT PREPARATIONS AND EQUIVALENT ALTERNATIVES The BMS has produced a document in response to the ongoing HRT shortages and to provide guidance to BMS members and clinical practitioners who may be NUFFIELD HEALTH LEEDS The BMS does not endorse the use of compounded bioidentical treatments. For an explanation of the difference between regulated (rBHRT) and compounded (cBHRT) bioidentical hormone therapy, please see the BMS Consensus Statement on Bioidentical HRT. HRT – PRACTICAL PRESCRIBING HRT – Practical prescribing Estradiol Estriol Conjugated estrogens > 0.5mg (combined only)/ 1mg / 2mg oral > 25mcg / 37.5mcg / 40mcg / 50mcg / 75mcg / 80mcg/ 100 mcg patches UNDERSTANDING THE RISKS OF BREAST CANCER March 2017 23 cases of breast cancer diagnosed in the UK general population An additional four cases in women on combined hormone replacement therapy (HRT)Skip to content
twitter youtube
* Contact BMS
* About the charity
* Our work
* Our people
* Our policies
* Links
Go to...
* Contact BMS
* About the charity
* Our work
* Our people
* Our policies
* Links
Members Area
* Home
* Join Us
* Benefits of Membership* Join online
* Find a Specialist
* Menopause Specialists* Overview
* Apply for certification * BMS Recognised Menopause Specialist Register form * Menopause Principal Trainers * Specialist Recertification* Education
* Overview
* Conferences and meetings * British Menopause Society Education Fund * FSRH Menopause Special Skills Module * BMS/RCOG Advanced Training Skills Module * Menopause education for nurses * IMPART online learning for health care professionals* Publications
* NICE Guideline
* Post Reproductive Health Journal* BMS Handbook
* BMS Vision
* Consensus Statements * Tools for Clinicians* Books
* Videos
* News
* About the charity
* Contact BMS
*
Search for:
Go to...
* Home
* Join Us
* Benefits of Membership* Join online
* Find a Specialist
* Menopause Specialists* Overview
* Apply for certification * BMS Recognised Menopause Specialist Register form * Menopause Principal Trainers * Specialist Recertification* Education
* Overview
* Conferences and meetings * British Menopause Society Education Fund * FSRH Menopause Special Skills Module * BMS/RCOG Advanced Training Skills Module * Menopause education for nurses * IMPART online learning for health care professionals* Publications
* NICE Guideline
* Post Reproductive Health Journal* BMS Handbook
* BMS Vision
* Consensus Statements * Tools for Clinicians* Books
* Videos
* News
* About the charity
* Contact BMS
HomeMariette-JB
2020-05-21T16:22:09+01:00 The British Menopause Society (BMS), established in
1989, educates, informs and guides healthcare professionals in all aspects of post reproductive health. This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal _Post Reproductive Health _ and the definitive handbook _Management of the Menopause_.
Following the statement from the Prime Minister on 17 March 2020 and the current government recommendations, we have closed the office. This is with effect until at least 30 June. Beyond that date, we will continue to follow government advice. _It will, however, be business as usual. _The best way to contact usis via email .
2020 BMS MAC Elections Full BMS members will be emailed on Tuesday 19 May with details of the 2020 Medical Advisory Council (MAC) elections, including the requirednomination form.
Completed nomination forms should be submitted VIA EMAIL and confirmation emails from proposers and seconders will be accepted, in place of signatures. The nomination form is also available in the members’ area of thewebsite.
12 hours CPD/CME points Post reproductive health for today’s clinicians Thursday 2 and Friday 3 July 2020 Royal College of Physicians, London BMS 30th Annual Scientific Conference POSTPONED TO 2021 SAVE THE DATE: Thursday 1 July to Friday 2 July 2021 Royal College of Physicians, London 3 hours CPD/CME points BMS Menopause Café Wednesday 1 July 2020, 1.00pm Royal College of Nursing, London Pre-conference workshop for registered healthcare professionals POSTPONED TO 2021 SAVE THE DATE: Wednesday 24 March 2021 Royal College of Nursing, London BMS launches ‘The Menopause Explained ’ Series 2 A second series of 7 short videos covering different aspects of the menopause. View videos New for 2020: British Menopause Society further update on HRT supply shortages 30 April 2020: The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in response to the ongoing HRT shortages. Find out more In the news: Sixth edition, published by the BMS in 2017, incorporates the recommendations for best practice from the NICE Guideline _Menopause: Diagnosis and Management_ Management of the Menopause BUY NOW > _“A rapid update of evidence-based guidance, which should improve the care of women in mid-life throughout the UK and beyond” _ Professor Mary Ann Lumsden On sale now... The essential handbook for healthcareprofessionals
working in post reproductive health Join us... BMS Members are valued as an essential part of our society, enjoying a wide range of membership benefits whilst providing vital support for our activities. Find out more Tools for clinicians To support women’s understanding of the menopause, the BMS has launched a number of materials for both women and healthcare professionals clarifying some of the most common myths and misconceptions of menopause, summarising the guideline, and providing guidance on HRT.BIOIDENTICAL HRT
The full BMS Consensus Statement on Bioidentical HRT is available to non-Members for a limited time only. EDUCATION PROGRAMME OVERVIEW MENOPAUSE – THE FOUNDATIONS 15 June 2020 - 16 June 2020 WOMEN’S HEALTH MEETING9 September 2020
WOMEN’S HEALTH MEETING17 September 2020
PRINCIPLES & PRACTICE OF MENOPAUSE CARE (BMS/FSRH MENOPAUSE SPECIAL SKILLS MODULE EQUIVALENT) 1 October 2020 - 2 October 2020 WOMEN’S HEALTH MEETING7 October 2020
'BEYOND CANCER - LIVING WITH AN INDUCED MENOPAUSE' STUDY DAY FORNURSES
12 October 2020
WOMEN’S HEALTH MEETING15 October 2020
POST REPRODUCTIVE HEALTH - JOINT RCOG/BMS MEETING 28 October 2020 - 29 October 2020 PRINCIPLES & PRACTICE OF MENOPAUSE CARE (BMS/FSRH MENOPAUSE SPECIAL SKILLS MODULE EQUIVALENT) 12 November 2020 - 13 November 2020 GERMAN MENOPAUSE SOCIETY ANNUAL SYMPOSIUM 2020 13 November 2020 - 14 November 2020 ANNUAL PROFESSIONAL DEVELOPMENT CONFERENCE 17 November 2020 - 19 November 2020 28TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY &INFERTILITY (COGI)
19 November 2020 - 21 November 2020 COGNITIVE BEHAVIOUR THERAPY FOR MENOPAUSE SYMPTOMS 19 November 2020 - 20 November 2020 Full meeting calendarLATEST NEWS
* How to manage HRT provision without face to face consultations during COVID-19 healthcare restrictions* 20 May 2020
* The Primary Care Women’s Health Forum has produced this guide for primary care practitioners in order to provide support for HRT provision during this time. * British Menopause Society further update on HRT supply shortages(30 April 2020)
* 4 May 2020
* The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in response to the ongoing HRTshortages.
* BMS comment on the RCOG/BSGE/BSGC guidance on heavy menstrualbleeding
* 31 March 2020
* BMS statement on the RCOG/BSGE/BGCS document on the management of irregular menstrual bleeding/postmenopausal bleeding. * HRT prescribing alert during Covid 19* 26 March 2020
* A joint statement from the BMS, RCOG, RCGP and FSRH. * Extended use of contraceptive implant and Mirena IUS* 23 March 2020
* FSRH has advised that the use of the Mirena IUS can be extended up to 6 years for contraception.More news
BMS TV: THE MENOPAUSE EXPLAINEDMore BMS videos
Search for:
OUR PATIENT ARM
Women’s Health Concern (WHC) was founded in 1979 and became the patient arm of the BMS in 2012. It provides an independent service to advise, reassure and educate women of all ages about their gynaecological and sexual health, wellbeing and lifestyle concerns. Information for non-professionals can also be found at MenopauseMatters .
AFFILIATIONS
The British Menopause Society is a specialist society associated with the Royal College of Obstetricians and Gynaecologists.
@BRMENOPAUSESOC
BMS @BrMenopauseSoc
21 May 1263428574817579009#clapforkeyworkers
Don't forget to CLAP tonight at 8pm Thank you to those who are proving food, keeping essential shops & services going, and the @NHS and all in health & social care.#ThankYouThursday
#StayHomeSaveLives
#COVID19Pandemic
#clapforourcarers
#clapforNHS
Reply on Twitter 1263428574817579009Retweet
on Twitter 1263428574817579009Like
on Twitter 12634285748175790091Retweet on Twitter
BMS
Retweeted
NAMS @MenopauseOrg
13 May 1260604633040523280 Menopause is a journey. First stop, #perimenopause . Learn about some common signs to look for on the guided #menopause tour. http://bit.ly/2LpzGxATwitter feed video.
Reply on Twitter 1260604633040523280Retweet
on Twitter 12606046330405232808Like
on Twitter 126060463304052328010BMS @BrMenopauseSoc
14 May 1260849833105121280#clapforkeyworkers
Don't forget to CLAP tonight at 8pm Thank you to those who are proving food, keeping essential shops & services going, and the @NHS and all in health & social care.#ThankYouThursday
#StayHomeSaveLives
#COVID19Pandemic
#clapforourcarers
#clapforNHS
Reply on Twitter 1260849833105121280Retweet
on Twitter 1260849833105121280Like
on Twitter 12608498331051212801Retweet on Twitter
BMS
Retweeted
International Menopause Society@IntlMenopause
13 May 1260491253881475074#OurMenopauseWorld
A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause.#IMS #OMW
#Menopause
#WomensHealth
Reply on Twitter 1260491253881475074Retweet
on Twitter 12604912538814750745Like
on Twitter 12604912538814750741Retweet on Twitter
BMS
Retweeted
RoyalCollegeObsGyn @RCObsGyn 12 May 1260118805369565185 Happy International Nurses' Day!👩🏽⚕️ We would like to thank all our nurses who provide amazing care and support during these challenging times 🙏🏽🌈🌍 #InternationalNursesDay#ThankOurNurses
Twitter feed video.
The RCN@theRCN
This Nurses' Day we want to say thank you to our amazing members and their colleagues for playing a vital role in the #COVID19 pandemic. Please share this film and say thank you to nursing staff everywhere using #NursesDay 💙 Reply on Twitter 1260118805369565185Retweet
on Twitter 12601188053695651853Like
on Twitter 12601188053695651857 CONFERENCE AND MEETING REPORTS THE BMS 29TH ANNUAL SCIENTIFIC CONFERENCE The 29th annual scientific conference, entitled “An integrated approach to menopausal care”, was held at Chesford Grange, Kenilworth on 4 & 5 July 2019.More reports
This site complies to the HONcode standard for trustworthy health information. Verify here Website last reviewed: May 2020 Women's Health Concern Registered Charity No. 279651. Registered Company No. 1432023.Patron: Penny Junor
Women's Health Concern is the patient arm of the British Menopause Society British Menopause Society Registered Charity No. 1015144. Registered Company No. 2759439.*
Terms of use
*
Privacy policy
*
Cookies
*
British Menopause Society*
Website by JacksonBone We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.OKMore about cookiesGo to Top
Previous Slide
Next Slide
Share
Facebook ShareTwitter ShareGoogle Plus ShareLinkedin SharePinterestShareEmail Share
TwitterTwitter
Hide Tweet (admin)
Add this ID to the plugin's HIDE SPECIFIC TWEETS setting:Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0